Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases.
Toru Ishibashi · Current pharmaceutical design · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. By drinking 500 ml of the high H₂ water daily for four weeks, oxidative stress was effectively reduced and the disease activity in RA was significantly improved. early diagnosis of the disease remains confounded by uncertainty. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. By drinking 500 ml of the high H₂ water daily for four weeks, oxidative stress was effectively reduced and the disease activity in RA was significantly improved.
What the Researchers Studied
The authors reviewed molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 2% source-reported H₂ gas concentration; reported treatment duration: 4 weeks. By drinking 500 ml of the high H₂ water daily for four weeks, oxidative stress was effectively reduced and the disease activity in RA was significantly improved. The authors concluded that early diagnosis of the disease remains confounded by uncertainty.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 2% source-reported H₂ gas concentration. The reported treatment duration was 4 weeks.
Limitations and Safety
Reported limitations: Also, early diagnosis of the disease remains confounded by uncertainty.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.